AzTrials
AzTrials

Tooth DemineralizationNCT07329244

Graphene-Reinforced CAD/CAM Restorations for MIH-Affected Molars in Adolescents: A Prospective Clinical Study

A study testing Graphene-reinforced CAD/CAM polymer (G-CAM®) in people with Tooth Demineralization and Tooth Sensitivity, run by Universitat Internacional de Catalunya at 1 site in Spain.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This study evaluates the clinical performance, marginal integrity, surface wear, color stability, and postoperative sensitivity of graphene-reinforced CAD/CAM indirect restorations (inlays, onlays, overlays) in molars affected by moderate to severe Molar-Incisor Hypomineralization (MIH) in adolescents. Read more about this study

Who is it for?
Ages 10 to 16 years
What is being tested?
Graphene-reinforced CAD/CAM polymer (G-CAM®)
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteSpain
Study dates
10 Jan 2026to 11 Jan 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 10 to 16 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Adolescents aged 10-16 years.
  • Permanent molars with moderate or severe MIH (EAPD criteria).
  • Vital and restorable teeth.
  • Ability to attend follow-up visits.
  • Informed consent from guardian + assent from the minor.

Who cannot join

  • Fluorosis, amelogenesis imperfecta, or other enamel defects.
  • Severe bruxism not controlled.
  • Active extensive caries or irreversible pulpitis.
  • Systemic conditions affecting enamel or healing.
  • Hypersensitivity/allergy to materials/adhesives.
  • Use of analgesics/AINEs <24 h before baseline VAS.
  • Orthodontic bands on the study molar.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Luis Carlos Garza Garza contact

+34938732017

luiscarlos@UIC.es

Spain1 site
  • Dental Esthetic BCN

    Sarrià-Sant Gervasi, Barcelona, 08034

    Luis Carlos Garza Garza

Other trials in Spain

About this study

Official title: Clinical Evaluation of Graphene-Reinforced CAD/CAM Indirect Restorations in Molars Affected by Molar-Incisor Hypomineralization (MIH) in Adolescents: A Clinical Study

This study evaluates the clinical performance, marginal integrity, surface wear, color stability, and postoperative sensitivity of graphene-reinforced CAD/CAM indirect restorations (inlays, onlays, overlays) in molars affected by moderate to severe Molar-Incisor Hypomineralization (MIH) in adolescents. A total of 30 patients aged 10-16 years will receive minimally invasive indirect restorations fabricated from a nano-reinforced graphene polymer (G-CAM®). Clinical outcomes will be assessed using FDI criteria, VAS sensitivity scores, patient satisfaction, and digital 3D scans over a 12-month follow-up. The study aims to determine clinical acceptability and safety compared with historical outcomes reported for composite and lithium-disilicate indirect restorations.

Read the detailed description

This is a prospective, single-arm, monocentric clinical trial designed to assess the functional performance, marginal adaptation, wear behavior, postoperative sensitivity, and structural preservation of graphene-reinforced CAD/CAM restorations placed on MIH-affected molars in adolescents aged 10-16 years. MIH lesions present compromised enamel quality with increased porosity, susceptibility to post-eruptive breakdown, and frequent hypersensitivity, making conventional restorative approaches less predictable.

Minimally invasive preparations will be performed followed by adhesive placement of graphene-reinforced CAD/CAM indirect restorations fabricated through a fully digital workflow (intraoral scanning, CAD design, CAM milling). Evaluations will be performed at baseline, 48 h, 1, 3, 6, and 12 months. Primary variables include global and domain-specific FDI clinical scores (marginal integrity, surface roughness, color stability, fractures/chipping, proximal contact, occlusion/function, soft tissue response) and postoperative sensitivity measured using a Visual Analog Scale (VAS). Secondary outcomes include patient satisfaction, tooth vitality, digital volumetric analysis of structural preservation, survival of restorations, and efficiency of the digital workflow.

Being tested
Graphene-reinforced CAD/CAM polymer (G-CAM®)
Keywords
molar-incisor hypomineralization, MIH, enamel defects, indirect restorations, minimally invasive dentistry, adhesive dentistry
Medical subject headings
Tooth Demineralization, Dentin Sensitivity, Molar Hypomineralization

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Graphene-reinforced CAD/CAM polymer (G-CAM®)Device

    Graphene-reinforced CAD/CAM polymer (G-CAM®) used for the fabrication of indirect inlay, onlay, or overlay restorations in permanent molars affected by molar-incisor hypomineralization (MIH). Restorations are fabricated using a digital CAD/CAM workflow and adhesively cemented under rubber dam isolation according to the study protocol.

Study groups in NCT07329244
Study groupRoleWhat they receive
Graphene-Reinforced CAD/CAM Indirect RestorationExperimentalMinimally invasive preparation, composite base build-up when indicated, adhesive protocol with total-etch technique, CAD/CAM fabrication using graphene-reinforced polymer (G-CAM®), adhesive cementation under rubber dam isolation, finishing and polishing, and follow-up at 1 week, 3, 6, and 12 months.
Receives: Device: Graphene-reinforced CAD/CAM polymer (G-CAM®)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Clinical Acceptability Assessed by the FDI World Dental Federation Clinical Criteria Score

    Clinical performance of the indirect CAD/CAM graphene-reinforced restoration will be evaluated using the FDI World Dental Federation Clinical Criteria.

    Each domain is scored on a 1-5 ordinal scale, where:

    1. = Clinically excellent (best outcome)
    2. = Clinically good
    3. = Clinically acceptable
    4. = Clinically unsatisfactory
    5. = Clinically poor (worst outcome)

    Domains assessed:

    Marginal integrity

    Surface roughness/wear

    Color stability

    Fractures/chipping

    Proximal contact

    Occlusion/function

    Soft tissue response

    Higher scores indicate worse clinical performance. Data will be reported as mean score per domain and global acceptability.

    Measured: 12 months after restoration placement

  2. Postoperative Sensitivity Measured by Visual Analog Scale (VAS 0-10)

    Postoperative sensitivity to cold and mastication will be measured on a 0-10 Visual Analog Scale (VAS), where:

    0 = No pain (best outcome)

    10 = Worst imaginable pain (worst outcome)

    Higher scores indicate worse sensitivity.

    Measured: Baseline (preoperative), 48 hours, 1 month, 3 months, 6 months, and 12 months

Secondary outcomes (2)
  1. Patient Satisfaction Measured by 5-Point Likert Scale

    Patient satisfaction with the restoration will be measured on a Likert scale from 1 to 5, where:

    1. = Very dissatisfied (worst outcome)
    2. = Dissatisfied
    3. = Neutral
    4. = Satisfied
    5. = Very satisfied (best outcome)

    Higher scores indicate higher satisfaction.

    Measured: 1 month, 3 months, 6 months, and 12 months

  2. Change in Tooth Structure Volume Measured by 3D Intraoral Scan Superimposition (mm³)

    Structural preservation will be evaluated by comparing preoperative and 12-month postoperative 3D intraoral scans.

    The primary metric is change in tooth volume (mm³) obtained through digital superimposition.

    Decreased volume indicates structural loss; minimal change indicates better preservation.

    Lower volume loss indicates better structural preservation.

    Measured: Baseline and 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Jan 2026
  2. Study start10 Jan 2026 (estimated)
  3. Primary completion23 Apr 2026 (estimated)
  4. Study completion11 Jan 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07329244
Sponsor's protocol ID
64/2025
Status last verified
Dec 2025
First submitted
30 Nov 2025
Last updated
9 Jan 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data (IPD) will not be shared with other researchers. The study involves pediatric participants, and all data will be pseudonymized and stored in secure, access-restricted servers according to GDPR and local ethics requirements. Because the dataset is small, contains sensitive clinical information from minors, and is collected within a single clinical center, sharing IPD may increase the risk of re-identification. Therefore, IPD will not be made available outside the research team.

Publications

  • Mendonca FL, Grizzo IC, Alencar CRB, Rios D. Restorative Therapy of MIH-Affected Molars. Monogr Oral Sci. 2024;32:236-260. doi: 10.1159/000538890. Epub 2024 Jul 1.

    PubMed 39321762
  • Somani C, Taylor GD, Garot E, Rouas P, Lygidakis NA, Wong FSL. An update of treatment modalities in children and adolescents with teeth affected by molar incisor hypomineralisation (MIH): a systematic review. Eur Arch Paediatr Dent. 2022 Feb;23(1):39-64. doi: 10.1007/s40368-021-00635-0. Epub 2021 Jun 10.

    PubMed 34110615

Questions about this trial

What is this clinical trial studying?

A study testing Graphene-reinforced CAD/CAM polymer (G-CAM®) in people with Tooth Demineralization and Tooth Sensitivity, run by Universitat Internacional de Catalunya at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 9 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Luis Carlos Garza Garza (+34938732017, luiscarlos@UIC.es), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Clinical Acceptability Assessed by the FDI World Dental Federation Clinical Criteria Score (time frame: 12 months after restoration placement). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07329244, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in